Literature DB >> 9503505

Papillary and metanephric adenomas of the kidney.

D J Grignon1, J N Eble.   

Abstract

Papillary renal adenomas are the commonest neoplasms of the renal tubular epithelium, occurring in up to 40% of adults. If these criteria are met, the diagnosis of adenoma can be made with confidence: (1) papillary, tubular, or tubulopapillary architecture; (2) diameter less than or equal to 5 mm; and (3) does not histologically resemble clear cell, chromophobe, or collecting duct renal cell carcinomas. They are composed of epithelial cells with variable amounts of cytoplasm with variable tinctorial qualities including clear. Metanephric adenoma and metanephric adenofibroma are closely related neoplasms that appear to be benign. Although they have a morphological resemblance to Wilms' tumor, there is some genetic evidence relating them to papillary adenoma and papillary renal cell carcinoma. Metanephric adenoma and metanephric adenofibroma occur at all ages, have a 2:1 predominance of female patients, and are associated with polycythemia. No instance of malignant behavior has been reported. The adenomatous component is composed of uniform small cells arranged in tubular or papillary architectural patterns. The fibromatous component is moderately cellular and composed of bland spindle cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9503505

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  10 in total

1.  Metanephric adenoma of the kidney: a clinicopathological and molecular study of two cases.

Authors:  Maximilian Burger; Kerstin Junker; Stefan Denzinger; Thomas Schubert; Robert Stoehr; Wolf-Ferdinand Wieland; Arndt Hartmann
Journal:  J Clin Pathol       Date:  2006-11-10       Impact factor: 3.411

2.  Author response: Papillary RCC and oncocytoma: Longer follow-up reported.

Authors:  Cevahir Ozer; Mehmet Resit Gören; Tulga Egilmez; Nebil Bal
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

Review 3.  Metanephric adenoma of the kidney: case report and review of the literature.

Authors:  H U Schmelz; M Stoschek; M Schwerer; B Danz; E W Hauck; W Weidner; C Sparwasser
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

4.  Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype.

Authors:  I A Lubensky; L Schmidt; Z Zhuang; G Weirich; S Pack; N Zambrano; M M Walther; P Choyke; W M Linehan; B Zbar
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

5.  Papillary renal cell carcinoma within a renal oncocytoma: case report of an incidental finding of a tumour within a tumour.

Authors:  Corwyn Rowsell; Neil Fleshner; Paula Marrano; Jeremy Squire; Andrew Evans
Journal:  J Clin Pathol       Date:  2007-04       Impact factor: 3.411

6.  The unexpected landscape of in vivo somatic mutation in a human epithelial cell lineage.

Authors:  Lorel M Colgin; Alden F M Hackmann; Mary J Emond; Raymond J Monnat
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

Review 7.  Recent classification of renal epithelial tumors.

Authors:  Naoto Kuroda; Azusa Tanaka
Journal:  Med Mol Morphol       Date:  2013-03-26       Impact factor: 2.309

8.  Adult metanephric adenoma presumed to be all benign? A clinical perspective.

Authors:  Gang Li; Yuhong Tang; Renya Zhang; Hualin Song; Shumin Zhang; Yuanjie Niu
Journal:  BMC Cancer       Date:  2015-04-25       Impact factor: 4.430

9.  Renal oncocytoma with prominent xanthomatous reaction. A rare histopathological variant of oncocytoma.

Authors:  José Fernando Val-Bernal; María Francisca Garijo; José Javier Gómez-Román
Journal:  Rom J Morphol Embryol       Date:  2021 Jul-Sep       Impact factor: 0.833

10.  Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation.

Authors:  Anna Caliò; John N Eble; Ondrej Hes; Guido Martignoni; Saul E Harari; Sean R Williamson; Matteo Brunelli; Adeboye O Osunkoya; Lisha Wang; Eva Comperat; Antonio Lopez-Beltran; Mingsheng Wang; Shaobo Zhang; Kendra L Curless; Kristin M Post; Hsim-Yee Chang; Claudio Luchini; Lee Ann Baldrige; Gregory T MacLennan; Rodolfo Montironi; David J Grignon; Liang Cheng
Journal:  Oncotarget       Date:  2016-08-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.